Biotech Gabapentin 100; 300 & 400 100 mg, 300 mg or 400 Capsules
PDF Leaflet Revision Date: 25 October 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Adjunctive therapy for seizure control.
Dosage (summary)
Initial: 300 mg TID; effective dose: 900-1800 mg/day.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- CNS depressants
- Opioids
- Antacids
Contraindications
- Hypersensitivity to gabapentin
- Children under 12
- Pregnancy and lactation
Common side effects
- Somnolence
- Dizziness
- Ataxia
- Nausea
Counselling Points
- Monitor for mood changes
- Avoid abrupt discontinuation
- Caution with driving and machinery
Serious warnings
- Severe cutaneous adverse reactions
- Anaphylaxis
- Suicidal ideation
Important Disclaimer
The Biotech Gabapentin 100; 300 & 400 100 mg, 300 mg or 400 Capsules professional information leaflet below is the property of Biotech Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
